Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

Semaglutide and tirzepatide medications have transformed weight loss, diabetes management, and overall health in recent years. Now, people in China will have access to Wegovy, potentially at a much lower price than in the United States.

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its........

© Salon